| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.001 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.16 | 0.002 |